Navigation Links
Valeant Pharmaceuticals Files a Notice of Intention to Make a Normal Course Issuer Bid
Date:8/23/2011

MISSISSAUGA, Ontario, Aug. 23, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (the "Company" or "Valeant") announced today that it has filed a Notice of Intention to make a normal course issuer bid with The Toronto Stock Exchange (the "TSX") and that the TSX has accepted the Notice of Intention. Under the bid, the Company will have the right to purchase for cancellation, commencing August 25, 2011, 1,000,000 of its Common Shares (representing approximately 0.33% of Valeant's Common Shares issued and outstanding as of the date hereof) through the facilities of the TSX, or such other means as may be permitted by the TSX. The Company may, at certain times, purchase its Common Shares if it believes that the market price of its Common Shares is attractive and that the purchase would be in the best interest of the Company and an appropriate use of corporate funds in light of potential benefits to remaining shareholders. The Company currently has approximately 299,587,764 Common Shares outstanding, and its average trading volume on the TSX for the six months prior to the date hereof is 462,572. For purposes of the TSX rules, a maximum of 115,643 common shares may be purchased by the Company on any one day under the bid, except where purchases are made in accordance with the "block purchase exception" of the TSX rules.

The normal course issuer bid is part of the Company's previously announced Securities Repurchase Program, pursuant to which the Company's Board of Directors has approved the purchase of up to 16 million Common Shares (representing approximately 10% of the Company's public float at the date of the announcement of the Securities Repurchase Program), 15 million of which have been approved for repurchase through the facilities of the NYSE (representing approximately 5% of Valeant's issued and outstanding common shares as of the date of the announcement of the Securities Repurchase Program). The Company currently intends to purchase th
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Valeant Pharmaceuticals Completes Acquisition of Sanitas Group
2. Valeant Pharmaceuticals Announces Resignation of Michael Van Every From Valeants Board of Directors
3. Valeant Pharmaceuticals Reports 2011 Second Quarter Financial Results
4. Valeant Pharmaceuticals Announces Approval of Sublinox® in Canada
5. Valeant Pharmaceuticals Announces Distribution Agreement for Zuacta™ in Canada
6. Valeant Pharmaceuticals Agrees to Acquire Ortho Dermatologics
7. Sanofi Divests Dermik Dermatology Unit to Valeant Pharmaceuticals International, Inc.
8. Valeant Pharmaceuticals Agrees to Acquire Dermik
9. Valeant Pharmaceuticals Announces License Agreement With Meda for North American Rights for Elidel® and Xerese™
10. Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results
11. Valeant Pharmaceuticals Congratulates Teva and Cephalon on Their Transaction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... -- Neuralstem, Inc. (NYSE MKT: CUR) today reported that ... presented updated Phase I data from its spinal cord-derived ... of amyotrophic lateral sclerosis (ALS or Lou ... medical symposium in Bucharest, Romania , ... in Stem Cell Therapy," Dr. Feldman outlined the design ...
(Date:5/20/2013)... CHICAGO, Ill. , May 20, 2013 /PRNewswire/ ... the initiation of a Phase 3 clinical study ... to assess the effects of the investigational compound ... progression of kidney disease in patients with stage ... type 2 diabetes.  SONAR is a large, multinational, ...
(Date:5/20/2013)... , May 20, 2013 With herbal medicines ... available from the U.S. Pharmacopeial Convention (USP) will provide ... of the herbal ingredients used in these products. Today, ... in the new Herbal Medicines Compendium ( ... at hmc.usp.org . HMC ...
Breaking Medicine Technology:Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 2AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 3AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 5AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 6New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 2New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 3
(Date:5/20/2013)... The automated external defibrillator market ... categories - semi-automated and fully automated defibrillators. Based ... categories, namely, hospitals, pre-hospital, public access, alternate care, ... Automated external defibrillators play an important role in ... Considering the life-saving potential of AEDs, legislations requiring ...
(Date:5/20/2013)... new healthcare bill proposes to have major ramifications in ... all the conditions were to be implemented or have ... 2014 to show anything. , According to Health ... forward to implement the health care law and establishing ... and West Virginia. HHS will continue to provide the ...
(Date:5/20/2013)... 20, 2013 Eben Pagan's ... the public creating a frenzy among business owners ... elite business training. WealthSpringMarketing.com's Tiffany Hendricks has published ... an exclusive bonus. , "Eben Pagan is a ... training to individuals serious about success," reports Hendricks. ...
(Date:5/20/2013)... According to a May 6, 2013 CBS ... Salons,” tanning salons in the US may soon ... Administration wants to see cancer warnings on indoor tanning ... of eighteen for the use of indoor tanning and sun ... has become increasingly common over the last few decades (Go ...
(Date:5/20/2013)... Lake City, UT (PRWEB) May 20, 2013 ... named one of Select Health’s Select 25 winners ... receive $2500 from Select Health. Know Greater Heroes is a ... local elementary schools to teach children how to eat right, ... student athletes participate in the Know Greater Heroes program each ...
Breaking Medicine News(10 mins):Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 2Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 3Health News:Review of Health Bill Impact in 2014 2Health News:Review of Health Bill Impact in 2014 3Health News:Eben Pagan's Accelerate: Review and Bonus Released By WealthSpringMarketing.com 2Health News:Tanning - FDA Wants Tanning Salons to Post Cancer Warning Signs 2Health News:SLCC Know Greater Heroes Program Named to Select 25 2Health News:SLCC Know Greater Heroes Program Named to Select 25 3
... Hologic, Inc. (Nasdaq: HOLX ) today announced that Glenn ... Global Healthcare Unplugged Conference in New York City on Tuesday, September ... Interested parties are invited to listen to a live audio ... company,s website at www.hologic.com/investor . An archive of ...
... , , , ... (Nasdaq: ZIXI ), the leader in email encryption services, today ... is a two-year extension of Humana,s original agreement which has now spanned ... ZixCorp licenses bringing the total to 36,000. , , ...
... in the September 2009 issue of the Journal of ... life prior to treatment can help predict the overall survival ... For those with advanced stage NSCLC, the median overall ... of patients surviving past the one year mark. To better ...
... study, approximately 20% of U.S. soldiers returning from Iraq ... substantial number with post-traumatic stress disorder (PTSD), and the ... unacceptable to Army commanders and the soldiers, families. ... doctors will now be able to forecast a soldier,s ...
... discounts, special promotions lead to greater alcohol consumption, study shows ... college bars lead to more intoxicated students and more health ... news that college students drink and the results can be ... the impact of drink discounts at college bars and found ...
... , , , WASHINGTON, Sept. ... flu, or H1N1 outbreak, in a recent article . , ... of the Mexican government in the fields of public awareness, rapid ... , The article noted "Mexico,s most effective action ...
Cached Medicine News:Health News:Zix Corporation and Humana Renew and Expand Exclusive Agreement 2Health News:Keeping the suicidal soldier alive 2Health News:College Students Get More Drunk When Drinks Are Cheap 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: